Ameriprise Financial, Inc. logo AMP - Ameriprise Financial, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
1
BUY 10
HOLD 10
SELL 1
STRONG
SELL
0
| PRICE TARGET: $514.00 DETAILS
HIGH: $582.00
LOW: $467.00
MEDIAN: $490.00
CONSENSUS: $514.00
UPSIDE: 13.51%

Stock News

Hightouch Launches Lifecycle Studio to Reinvent Lifecycle Marketing with Agentic AI

Hightouch Launches Lifecycle Studio to Reinvent Lifecycle Marketing with Agentic AI

SAN FRANCISCO--(BUSINESS WIRE)--Hightouch, the leader in data and AI for marketing, today announced Lifecycle Studio, a workspace for marketing teams to create and execute on-brand, personalized campaigns in minutes. The second studio within its Agentic Marketing Platform (AMP), Lifecycle Studio allows marketers to use agents grounded in the complete context of their brand, customers, and campaign history to execute production-ready, cross channel campaigns. For more than a decade, lifecycle ma.

Jun 24, 2026 05:00 AM businesswire.com
Ameriprise Financial: Recurring Revenues, High ROE, And Still Moderate Valuation

Ameriprise Financial: Recurring Revenues, High ROE, And Still Moderate Valuation

Ameriprise Financial delivers strong recurring revenues and robust 30% operating margins in Advice & Wealth Management, with AUM/AUA reaching a record $1.7 trillion. AMP trades at a discounted 11.2x P/E, below its five-year average and peers, despite superior 54.3% ROE and aggressive capital returns via buybacks and dividends. Business transformation to a fee-based, low-capital-intensive model enhances stability, while advisor productivity and AUM/AUA growth support long-term earnings power.

Jun 16, 2026 01:35 AM seekingalpha.com
Ameriprise Financial: AI Cash Optimization Fears Create Opportunity (Upgrade)

Ameriprise Financial: AI Cash Optimization Fears Create Opportunity (Upgrade)

Ameriprise Financial has underperformed, but I see AI-driven fears over cash sweep revenue as overdone, given AMP's diversified model. AMP's Q1 earnings were strong, with $11.26 EPS, 9% revenue growth, and 150bps margin expansion, aided by robust AUM growth and advisor productivity. I expect 2026 EPS of $44–$45.50, up from prior estimates, as market gains and stable rates boost advisory and cash revenue.

Jun 15, 2026 10:11 AM seekingalpha.com
AM Best Assigns Issue Credit Ratings to Ameriprise Financial, Inc.'s New Senior Unsecured Notes

AM Best Assigns Issue Credit Ratings to Ameriprise Financial, Inc.'s New Senior Unsecured Notes

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has assigned a Long-Term Issue Credit Rating of “a-” (Excellent) to Ameriprise Financial, Inc.'s (Ameriprise) (Minneapolis, MN) recently announced USD 300 million, 4.8% senior unsecured notes, due 2031, and the USD 450 million, 5.35% senior unsecured notes, due 2036. The outlook assigned to these Credit Ratings (ratings) is stable.Proceeds from the offering are being used for general corporate purposes, including the repayment of outstanding senior notes m.

Jun 11, 2026 11:31 AM businesswire.com
Ameriprise Financial Earns Technology Innovation Award for its Ameriprise® Signature Wealth Program

Ameriprise Financial Earns Technology Innovation Award for its Ameriprise® Signature Wealth Program

MINNEAPOLIS--(BUSINESS WIRE)--Ameriprise Financial (NYSE: AMP) today announced it has received the 2026 Technology Innovation Award from the Bank Insurance & Securities Association (BISA). This award recognizes the Ameriprise® Signature Wealth Program, a flexible unified managed account (UMA) that enables advisors to seamlessly combine multiple investment options and management methods into one portfolio. The Signature Wealth Program transforms investing processes by allowing advisors to bu.

Jun 11, 2026 08:29 AM businesswire.com
Arima Genomics to Present Data at AMP Europe Showing Hi-C Sequencing Outperforms High-Coverage Whole Genome Sequencing for Lymphoma Rearrangement Detection

Arima Genomics to Present Data at AMP Europe Showing Hi-C Sequencing Outperforms High-Coverage Whole Genome Sequencing for Lymphoma Rearrangement Detection

CARLSBAD, Calif.--(BUSINESS WIRE)--Arima Genomics, Inc., a cancer diagnostics company bringing DNA sequence and structure together to advance cancer therapy selection, today announced new data to be presented at the Association for Molecular Pathology (AMP) 2026 Europe Congress, taking place June 15–17, 2026, in Tallinn, Estonia. The new findings demonstrate that Arima's Hi-C sequencing-based approach, available clinically through the Aventa™ Lymphoma test, identified clinically relevant lympho.

Jun 11, 2026 04:00 AM businesswire.com
Experienced Advisor with More Than $120 Million in Assets Joins Ameriprise Financial for Independence and Growth Opportunities

Experienced Advisor with More Than $120 Million in Assets Joins Ameriprise Financial for Independence and Growth Opportunities

MINNEAPOLIS--(BUSINESS WIRE)--Private wealth advisor Russell Austin recently joined the independent channel of Ameriprise Financial, Inc. (NYSE: AMP) from Edward Jones in Spartanburg, S.C., where he managed more than $120 million in client assets. His practice, Freedom Ridge Private Wealth, includes client relationship manager Pamela Jones. Austin chose Ameriprise for greater independence and a culture that supports long-term growth. After evaluating multiple firms, the combination of advanced.

Jun 09, 2026 05:03 AM businesswire.com
Experienced Advisory Team With $160 Million in Assets Joins Ameriprise Financial for Enhanced Client Experience and Advanced Capabilities

Experienced Advisory Team With $160 Million in Assets Joins Ameriprise Financial for Enhanced Client Experience and Advanced Capabilities

MINNEAPOLIS--(BUSINESS WIRE)--Pattern Wealth, a private wealth advisory practice, recently joined the branch channel of Ameriprise Financial, Inc. (NYSE: AMP) from Thrivent Investment Management, Inc. with $160 million in client assets. The practice, located in Wayzata, Minn., is led by private wealth advisor Jeremy Jackson and includes his father, financial advisor Dave Jackson, and client service associate Erika Holland. The team, which brings decades of combined industry experience, chose to.

Jun 03, 2026 07:32 AM businesswire.com
Elicio Therapeutics Announces Publication in Peer-Reviewed Journal Science Advances Highlighting Potent and Durable Immune Responses Driven by Company's AMP-DNA Adjuvant Technology

Elicio Therapeutics Announces Publication in Peer-Reviewed Journal Science Advances Highlighting Potent and Durable Immune Responses Driven by Company's AMP-DNA Adjuvant Technology

BOSTON, June 01, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, today announced the publication of a peer-reviewed manuscript in Science Advances, published by the American Association for the Advancement of Science, describing a series of novel AMP-DNA adjuvant candidates built from the lymph node-targeting Amphiphile (“AMP”) platform technology.   The manuscript, titled “Lymph node targeted DNA engages TBK1/IFN-I driven innate immunity to induce potent T cell responses and durable memory in mice and NHPs,” highlights the ability of these preclinical novel AMP-DNA adjuvants to drive robust, durable immune responses through targeted delivery to lymph nodes and activation of innate immune pathways.

Jun 01, 2026 04:00 AM globenewswire.com
Columbia Threadneedle Investments Announces Retirement of Global Chief Investment Officer

Columbia Threadneedle Investments Announces Retirement of Global Chief Investment Officer

BOSTON & LONDON--(BUSINESS WIRE)--Columbia Threadneedle Investments, the global asset management group of Ameriprise Financial (NYSE: AMP), today announced that William Davies, global chief investment officer, has decided to retire after 33 years of distinguished service to the firm and its clients. Mr. Davies' retirement will be effective on June 30, 2026. William F. "Ted" Truscott, chief executive officer of Columbia Threadneedle, will act as interim global chief investment officer from July.

May 20, 2026 06:00 AM businesswire.com

Price Targets